propranolol has been researched along with Orbital Neoplasms in 37 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Orbital Neoplasms: Neoplasms of the bony orbit and contents except the eyeball.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent reports of propranolol for the treatment of hemangiomas have led many physicians to question the best treatment strategy for children with vision-threatening hemangiomas." | 8.89 | Hemangiomas treated with propranolol: do the rewards outweigh the risks? ( Haider, KM; Neely, DE; Plager, DA, 2013) |
| "To highlight the importance of Magnetic Resonance Imaging (MRI) and the use of propranolol as both a final diagnostic tool and adequate treatment for orbital Infantile Haemangiomas (IHs)." | 7.80 | Propranolol as first-line treatment in orbital infantile haemangiomas: a case series. ( Coumou, AD; Freling, NJ; Groeneveld, L; Levitt, M; Saeed, P; van der Horst, CM, 2014) |
| "To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management." | 7.80 | Monitoring propranolol treatment in periocular infantile haemangioma. ( Burne, R; Taylor, R, 2014) |
| "Propranolol is now widely used to treat severe infantile haemangiomas (IHs)." | 7.79 | Propranolol-resistant infantile haemangiomas. ( Aubert, H; Barbarot, S; Boccara, O; Bursztejn, AC; Caussé, S; Chiaverini, C; Dreyfus, I; Eschard, C; Hadj-Rabia, S; Mahé, E; Maruani, A; Mazereeuw-Hautier, J; Miquel, J; Puzenat, E; Saint-Jean, M; Stalder, JF, 2013) |
| "3 months) with periorbital proliferating phase infantile hemangioma underwent oral propranolol therapy." | 7.77 | [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma]. ( Fu, HB; Guo, X; Huo, R; Lin, LL; Lü, RR; Wui, JC; Xu, GQ; Zhang, J; Zhao, ZF, 2011) |
| "Propranolol is a promising treatment against infantile haemangiomas in the orbit, not only in infants but also in an older child with a stable lesion." | 7.76 | Successful treatment of infantile haemangiomas of the orbit with propranolol. ( Li, YC; Martin, FJ; Martin, PA; McCahon, E; Rowe, NA; Wilcsek, GA, 2010) |
| "Propranolol appears to be a safe and effective treatment in the management of infantile haemangioma." | 7.76 | Propranolol in the management of periorbital infantile haemangioma. ( Cheng, JF; Gole, GA; Sullivan, TJ, 2010) |
| "Outpatient propranolol treatment reduced the size or stopped the growth of all hemangiomas treated, with excellent response in more than half of all patients treated and only minor side effects." | 7.76 | Outpatient treatment of periocular infantile hemangiomas with oral propranolol. ( Eikenberry, J; Haggstrom, A; Haider, KM; Neely, DE; Plager, DA, 2010) |
| "Recent reports of propranolol for the treatment of hemangiomas have led many physicians to question the best treatment strategy for children with vision-threatening hemangiomas." | 4.89 | Hemangiomas treated with propranolol: do the rewards outweigh the risks? ( Haider, KM; Neely, DE; Plager, DA, 2013) |
| "To the best of our knowledge, this is the first observation of a secondary congenital glaucoma reversal with oral propranolol used for orbital IH management." | 3.91 | Secondary Congenital Glaucoma Associated With Retro-orbital Infantile Hemangioma: A Masquerade Syndrome. ( Beylerian, M; Dambricourt, L; Denis, D; Matonti, F; Ramtohul, P, 2019) |
| "To highlight the importance of Magnetic Resonance Imaging (MRI) and the use of propranolol as both a final diagnostic tool and adequate treatment for orbital Infantile Haemangiomas (IHs)." | 3.80 | Propranolol as first-line treatment in orbital infantile haemangiomas: a case series. ( Coumou, AD; Freling, NJ; Groeneveld, L; Levitt, M; Saeed, P; van der Horst, CM, 2014) |
| "To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management." | 3.80 | Monitoring propranolol treatment in periocular infantile haemangioma. ( Burne, R; Taylor, R, 2014) |
| "Propranolol is now widely used to treat severe infantile haemangiomas (IHs)." | 3.79 | Propranolol-resistant infantile haemangiomas. ( Aubert, H; Barbarot, S; Boccara, O; Bursztejn, AC; Caussé, S; Chiaverini, C; Dreyfus, I; Eschard, C; Hadj-Rabia, S; Mahé, E; Maruani, A; Mazereeuw-Hautier, J; Miquel, J; Puzenat, E; Saint-Jean, M; Stalder, JF, 2013) |
| "3 months) with periorbital proliferating phase infantile hemangioma underwent oral propranolol therapy." | 3.77 | [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma]. ( Fu, HB; Guo, X; Huo, R; Lin, LL; Lü, RR; Wui, JC; Xu, GQ; Zhang, J; Zhao, ZF, 2011) |
| "Propranolol is a promising treatment against infantile haemangiomas in the orbit, not only in infants but also in an older child with a stable lesion." | 3.76 | Successful treatment of infantile haemangiomas of the orbit with propranolol. ( Li, YC; Martin, FJ; Martin, PA; McCahon, E; Rowe, NA; Wilcsek, GA, 2010) |
| "Propranolol appears to be a safe and effective treatment in the management of infantile haemangioma." | 3.76 | Propranolol in the management of periorbital infantile haemangioma. ( Cheng, JF; Gole, GA; Sullivan, TJ, 2010) |
| "Outpatient propranolol treatment reduced the size or stopped the growth of all hemangiomas treated, with excellent response in more than half of all patients treated and only minor side effects." | 3.76 | Outpatient treatment of periocular infantile hemangiomas with oral propranolol. ( Eikenberry, J; Haggstrom, A; Haider, KM; Neely, DE; Plager, DA, 2010) |
| "To evaluate the medical literature on the use of β-blockers, through different routes, for the treatment of periorbital infantile hemangiomas and to summarize the recommendations available on dosage and monitoring." | 2.61 | β-blockers in the treatment of periocular infantile hemangioma. ( Al-Haddad, C; El Moussawi, Z; El Salloukh, NA, 2019) |
| " As per the guideline, a preliminary paediatric assessment was performed and a 1 mg/kg test dose was administered, followed by definitive treatment at a dosage of 2 mg/kg in three divided doses." | 2.61 | Orbital infantile haemangioma: radiological features and treatment - case series and literature review. ( Albanese, G; Mohandas, P; Ravenscroft, J; Srinivasan, J; Tambe, K; Taylor, T; Thomas, S; Wells, L, 2019) |
| " Additional research may confirm the best dosage and route of administration to maximize efficacy in reducing induced astigmatism and amblyopia associated with periocular hemangiomas while minimizing side effects." | 2.61 | The Use of β-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology. ( Galvin, JA; Hutchinson, AK; Kraker, RT; Lambert, SR; Pineles, SL; VanderVeen, DK; Wilson, LB, 2019) |
| "Propranolol has been suggested as the new standard of care for treatment of IH." | 2.49 | Infantile hemangioma: treatment with surgery or steroids. ( Mawn, LA, 2013) |
| "Propranolol has recently been reported to be an effective and safe alternative." | 2.47 | The use of propranolol in the management of periocular capillary haemangioma--a systematic review. ( Reddy, AR; Spiteri Cornish, K, 2011) |
| "Mean astigmatism in affected eyes was 1." | 1.43 | Visual acuity and astigmatism in periocular infantile hemangiomas treated with oral beta-blocker versus intralesional corticosteroid injection. ( Herlihy, EP; Kelly, JP; Perkins, JA; Sidbury, R; Weiss, AH, 2016) |
| "Adult hemangiomas are usually benign vascular tumors presenting as painless progressive proptosis, sometimes accompanied by serious visual loss due to compression of the optic nerve." | 1.38 | Management of adult onset orbital hemangioma by oral propranalol: a case report. ( Goswami, M; Murthy, GJ, 2012) |
| "Oral propranolol for treatment of infantile hemangiomas was effective in all patients, with 33% reduction in astigmatism and 39% reduction in surface area." | 1.37 | Oral propranolol for treatment of periocular infantile hemangiomas. ( Bayliss, SJ; Gilbertson, K; Lueder, GT; Missoi, TG, 2011) |
| " A treatment dosage of 2 mg/kg per day was started at mean age 5." | 1.37 | Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. ( Ben-Amitay, D; Friling, R; Goldenberg-Cohen, N; Reich, U; Ron, Y; Siegel, R; Snir, M; Zvulunov, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 36 (97.30) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Haddad, C | 1 |
| El Salloukh, NA | 1 |
| El Moussawi, Z | 1 |
| Mehta, A | 1 |
| Bajaj, MS | 1 |
| Pushker, N | 1 |
| Chawla, B | 1 |
| Pujari, A | 1 |
| Grewal, SS | 1 |
| Grewal, SPS | 1 |
| Singh, SR | 1 |
| Kishore, A | 1 |
| Yadav, NS | 1 |
| Sazali, HB | 1 |
| Allen, NM | 1 |
| Murphy, A | 1 |
| Albanese, G | 1 |
| Mohandas, P | 1 |
| Wells, L | 1 |
| Ravenscroft, J | 1 |
| Srinivasan, J | 1 |
| Thomas, S | 1 |
| Taylor, T | 1 |
| Tambe, K | 1 |
| Hutchinson, AK | 1 |
| Kraker, RT | 1 |
| Pineles, SL | 1 |
| VanderVeen, DK | 1 |
| Wilson, LB | 1 |
| Galvin, JA | 1 |
| Lambert, SR | 1 |
| Lee, SM | 1 |
| Khwarg, SI | 1 |
| Ahn, JH | 1 |
| Ramtohul, P | 1 |
| Beylerian, M | 1 |
| Dambricourt, L | 1 |
| Matonti, F | 1 |
| Denis, D | 1 |
| Caussé, S | 1 |
| Aubert, H | 1 |
| Saint-Jean, M | 1 |
| Puzenat, E | 1 |
| Bursztejn, AC | 1 |
| Eschard, C | 1 |
| Mahé, E | 1 |
| Maruani, A | 1 |
| Mazereeuw-Hautier, J | 1 |
| Dreyfus, I | 1 |
| Miquel, J | 1 |
| Chiaverini, C | 1 |
| Boccara, O | 1 |
| Hadj-Rabia, S | 1 |
| Stalder, JF | 1 |
| Barbarot, S | 1 |
| Haider, KM | 2 |
| Neely, DE | 2 |
| Plager, DA | 2 |
| Mawn, LA | 1 |
| Puligadda, RK | 1 |
| Vijayalakshmi, B | 1 |
| Levitt, M | 1 |
| Coumou, AD | 1 |
| Groeneveld, L | 1 |
| Freling, NJ | 1 |
| van der Horst, CM | 1 |
| Saeed, P | 1 |
| Xu, S | 1 |
| Jia, R | 1 |
| Ge, S | 1 |
| Lin, M | 1 |
| Fan, X | 1 |
| Burne, R | 1 |
| Taylor, R | 1 |
| Sterker, I | 1 |
| Tegetmeyer, H | 1 |
| Sorge, I | 1 |
| Weißer, M | 1 |
| Böhm, R | 1 |
| Herlihy, EP | 1 |
| Kelly, JP | 1 |
| Sidbury, R | 1 |
| Perkins, JA | 1 |
| Weiss, AH | 1 |
| Taban, M | 1 |
| Goldberg, RA | 1 |
| Fay, A | 1 |
| Nguyen, J | 1 |
| Jakobiec, FA | 1 |
| Meyer-Junghaenel, L | 1 |
| Waner, M | 1 |
| Li, YC | 1 |
| McCahon, E | 1 |
| Rowe, NA | 1 |
| Martin, PA | 1 |
| Wilcsek, GA | 1 |
| Martin, FJ | 1 |
| Cheng, JF | 1 |
| Gole, GA | 1 |
| Sullivan, TJ | 1 |
| Cruz, OA | 1 |
| Siegfried, EC | 1 |
| Eikenberry, J | 1 |
| Haggstrom, A | 1 |
| Sloan, B | 1 |
| Mora, J | 1 |
| Dai, S | 1 |
| Claerhout, I | 1 |
| Buijsrogge, M | 1 |
| Delbeke, P | 1 |
| Walraedt, S | 1 |
| De Schepper, S | 1 |
| De Moerloose, B | 1 |
| De Groote, K | 1 |
| Decock, C | 1 |
| Mai, C | 1 |
| Vega-Pérez, A | 1 |
| Koch, M | 1 |
| Bertelmann, E | 1 |
| Missoi, TG | 1 |
| Lueder, GT | 1 |
| Gilbertson, K | 1 |
| Bayliss, SJ | 1 |
| Spierer, O | 1 |
| Neudorfer, M | 1 |
| Leibovitch, I | 1 |
| Stolovitch, C | 1 |
| Kessler, A | 1 |
| Thoumazet, F | 1 |
| Léauté-Labrèze, C | 1 |
| Colin, J | 1 |
| Mortemousque, B | 1 |
| Spiteri Cornish, K | 1 |
| Reddy, AR | 1 |
| Zhao, ZF | 1 |
| Lü, RR | 1 |
| Zhang, J | 1 |
| Huo, R | 1 |
| Xu, GQ | 1 |
| Fu, HB | 1 |
| Guo, X | 1 |
| Wui, JC | 1 |
| Lin, LL | 1 |
| Snir, M | 1 |
| Reich, U | 1 |
| Siegel, R | 1 |
| Zvulunov, A | 1 |
| Friling, R | 1 |
| Goldenberg-Cohen, N | 1 |
| Ron, Y | 1 |
| Ben-Amitay, D | 1 |
| Aletaha, M | 1 |
| Salour, H | 1 |
| Bagheri, A | 1 |
| Raffati, N | 1 |
| Amouhashemi, N | 1 |
| Clifford, L | 1 |
| May, K | 1 |
| Norris, JH | 1 |
| McCulloch, PG | 1 |
| Murthy, GJ | 1 |
| Goswami, M | 1 |
| Xue, K | 1 |
| Hildebrand, GD | 1 |
| Salazar-Murillo, R | 1 |
| García-Pacheco, S | 1 |
| González-Blanco, MJ | 1 |
| Bolívar-Montesa, P | 1 |
| Campos-García, S | 1 |
9 reviews available for propranolol and Orbital Neoplasms
| Article | Year |
|---|---|
β-blockers in the treatment of periocular infantile hemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Female; Hemangioma, Capillary; Humans; Infant; Ma | 2019 |
Orbital infantile haemangioma: radiological features and treatment - case series and literature review.
Topics: Female; Hemangioma, Capillary; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Or | 2019 |
The Use of β-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Hemangiom | 2019 |
Hemangiomas treated with propranolol: do the rewards outweigh the risks?
Topics: Adrenergic beta-Antagonists; Child; Hemangioma; Humans; Orbital Neoplasms; Propranolol; Treatment Ou | 2013 |
Infantile hemangioma: treatment with surgery or steroids.
Topics: Adrenergic beta-Antagonists; Glucocorticoids; Hemangioma; Humans; Infant; Ophthalmologic Surgical Pr | 2013 |
Treatment of periorbital infantile haemangiomas: a systematic literature review on propranolol or steroids.
Topics: Adrenal Cortex Hormones; Hemangioma, Capillary; Humans; Infant; Orbital Neoplasms; Propranolol; Vaso | 2014 |
[Propranolol therapy for periocular and orbital infantile haemangiomas].
Topics: Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Infant, Newborn; Male; Orbital Neoplasms; P | 2014 |
The use of propranolol in the treatment of periocular infantile haemangiomas: a review.
Topics: Adrenergic beta-Antagonists; Disease Progression; Eye Neoplasms; Hemangioma, Capillary; Humans; Infa | 2011 |
The use of propranolol in the management of periocular capillary haemangioma--a systematic review.
Topics: Administration, Oral; Antineoplastic Agents; Child, Preschool; Disease Progression; Evidence-Based M | 2011 |
1 trial available for propranolol and Orbital Neoplasms
| Article | Year |
|---|---|
To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; | 2019 |
27 other studies available for propranolol and Orbital Neoplasms
| Article | Year |
|---|---|
PHACE syndrome: importance of distinguishing infantile haemangioma from capillary malformation.
Topics: Adrenergic beta-Antagonists; Aortic Coarctation; Diagnosis, Differential; Eye Abnormalities; Female; | 2020 |
Epithelioid hemangioma of the orbit treated with oral propranolol in adult.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Hemangioma; Hum | 2018 |
Secondary Congenital Glaucoma Associated With Retro-orbital Infantile Hemangioma: A Masquerade Syndrome.
Topics: Diagnosis, Differential; Female; Glaucoma; Hemangioma; Humans; Hydrophthalmos; Infant; Intraocular P | 2019 |
Propranolol-resistant infantile haemangiomas.
Topics: Age of Onset; Antineoplastic Agents; Child, Preschool; Drug Resistance, Neoplasm; Facial Neoplasms; | 2013 |
Large orbital hemangioma: managed with systemic propranolol.
Topics: Administration, Oral; Hemangioma; Humans; Infant; Male; Orbital Neoplasms; Propranolol | 2014 |
Propranolol as first-line treatment in orbital infantile haemangiomas: a case series.
Topics: Administration, Oral; Contrast Media; Female; Hemangioma; Humans; Infant; Magnetic Resonance Imaging | 2014 |
Monitoring propranolol treatment in periocular infantile haemangioma.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Amblyopia; Child; Child, Preschool; D | 2014 |
Visual acuity and astigmatism in periocular infantile hemangiomas treated with oral beta-blocker versus intralesional corticosteroid injection.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Astigmatism; Eyelid Neoplasms; Female; Glucocorti | 2016 |
Propranolol for orbital hemangioma.
Topics: Adrenergic beta-Antagonists; Female; Hemangioma, Capillary; Humans; Infant; Magnetic Resonance Imagi | 2010 |
Propranolol for isolated orbital infantile hemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Biomarkers, Tumor; Female; Hemangioma; Humans; In | 2010 |
Successful treatment of infantile haemangiomas of the orbit with propranolol.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Female; Hemangioma; Humans; Infant; Magnetic Resonanc | 2010 |
Propranolol in the management of periorbital infantile haemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Astigmatism; Eyelid Neoplasms; Female; Hemangioma | 2010 |
Propranolol treatment for periocular capillary hemangiomas.
Topics: Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Orbital Neoplasms; Propranolol | 2010 |
Outpatient treatment of periocular infantile hemangiomas with oral propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Infant, Newborn; Orbi | 2010 |
Everything old is new again.
Topics: Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Orbital Neoplasms; Propranolol | 2010 |
[Successful treatment of orbital capillary hemangioma with propranolol].
Topics: Adrenergic beta-Antagonists; Biopsy; Exophthalmos; Female; Hemangioma, Capillary; Humans; Infant; Ma | 2011 |
Oral propranolol for treatment of periocular infantile hemangiomas.
Topics: Administration, Oral; Antineoplastic Agents; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, | 2011 |
Colour Doppler ultrasound imaging findings in paediatric periocular and orbital haemangiomas.
Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Eyelid Neoplasms; Female; Follow-Up Studies; Gluco | 2012 |
Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Follow-Up Stu | 2012 |
[Oral propranolol in the management of periorbital proliferating phase infantile hemangioma].
Topics: Child; Child, Preschool; Female; Hemangioma; Humans; Infant; Male; Orbital Neoplasms; Propranolol; R | 2011 |
Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; | 2011 |
Successful treatment of orbital hemangioma with propranolol in a 5-year-old girl.
Topics: Child, Preschool; Female; Hemangioma, Capillary; Humans; Orbital Neoplasms; Propranolol | 2012 |
Reply to Spiteri Cornish and Reddy.
Topics: Antineoplastic Agents; Female; Hemangioma, Capillary; Humans; Male; Orbital Neoplasms; Propranolol | 2012 |
Re: The use of propranolol in the management of periocular capillary haemangioma--a systematic review.
Topics: Antineoplastic Agents; Female; Hemangioma, Capillary; Humans; Male; Orbital Neoplasms; Propranolol | 2012 |
Management of adult onset orbital hemangioma by oral propranalol: a case report.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Diagnosis, Differential; Female; Hemangioma; Huma | 2012 |
Topical timolol maleate 0.5% for infantile capillary haemangioma of the eyelid.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Orbital Neoplasms; Pro | 2012 |
[Propranolol: Treatment of capillary hemangioma with orbital involvement].
Topics: Disease Progression; Eyelid Neoplasms; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Infa | 2012 |